Discovery and Development of Oral Small-molecule Direct-acting Antivirals
$499,825N43FY2025AINIH
Eydis Bio, Inc., Durham NC
Investigators
Abstract
To develop broad-spectrum treatments for flaviviruses.
View original record on NIH RePORTER →Eydis Bio, Inc., Durham NC
To develop broad-spectrum treatments for flaviviruses.
View original record on NIH RePORTER →